Johnson & Johnson MedTech Announces CE Mark Approval for Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter 10 January 2025 Johnson & Johnson MedTech Joins Experts to Define and Classify Surgical Site Outcomes 09 December 2024 The Evolving Landscape of Atrial Fibrillation Ablation: VARIPULSE™ ...
jjmedtech代表的是京美德医疗科技有限公司。这家公司位于中国深圳，主要提供医疗器械的专业技术开发、技术转让、技术服务以及技术咨询。此外，京美德还从事各类货物及技术的进出口业务，并生产和销售医疗器械。
Introducing J&J MedTech My Health Can’t Wait Government & Policy Johnson & Johnson report: Getting Australia to the front of the queue Report focuses on how to provide a pathway to faster access to innovative medicines and medical technologies for Australia. ...
February 14, 2025—Johnson & Johnson MedTech recently launched their Cereglide 92 catheter system for the treatment of acute ischemic stroke. Cereglide 92 is a 0.092-inch catheter with Innerglide 9 delivery aid indicated for use in facilitating the insertion and guidance of interventional devic...
Johnson & Johnson MedTech has given itself a new deadline for the development of its long-awaited entrant into the globally competitive robotic surgery market. The company said that in the latter half of next year, it plans to request the FDA’s permission to begin U.S. clinical studi...
J&J Medtech announced the FDA clearance of its dual-use robotics platform Velys Spine with plans to go to market in the first half of 2025. • Source: Alamy Johnson & Johnson MecTech says it has received US Food and Drug Administration 510(k) clearance for its first robotic-assisted...
Guided by a clear, consistent investment strategy aligned with the scientific goals of Johnson & Johnson, JJDC works hand-in-hand with partners to help navigate the path to creating breakthrough health innovations. We invest across sectors—pharmaceuticals and medtech—and at all stages, from new...
Guided by a clear, consistent investment strategy aligned with the scientific goals of Johnson & Johnson, JJDC works hand-in-hand with partners to help navigate the path to creating breakthrough health innovations. We invest across sectors—pharmaceuticals and medtech—and at all stages, from new...
Johnson & JohnsonMedTech innovates at the intersection of biology and technology. With a focus on treating with pinpoint precision in the hardest-to-reach parts of the body, restoring anatomy and reimagining healing, our portfolio of smarter, less invasive, more personalized treatments is addressin...
Medtech Startups Competing with Medtronic, J&J, Boston Scientific VenoStent is developing a novel memory polymer for intravascular devicesThe company is seeking to improve venous access in hemodialysis patients with its novel shape memory polymer technology. To-date the company has raised $1.3M...